Skip to main content

Past Event
10 May 2011 - 11 May 2011

6th Annual In-House Counsel Forum on Pharmaceutical Antitrust

Hear from government regulators, in-house pharmaceutical counsel, and expert attorneys on the front lines of the complex antitrust issues currently facing brand name and generic pharmaceutical manufacturers and learn how to:

  • Structure reverse settlement payment agreements that align with FTC concerns
  • Negotiate mergers in the wake of Pfizer/Wyeth, Teva/Barr and the revised Guidelines
  • Comprehend the impact of Ovation on product acquisitions
  • Update life cycle management strategies, including product migration, authorized generics and tactics for follow-on biologic products Navigate increased overseas focus by global regulators
  • Work more effectively with the FtC by gaining greater understanding of how the Commission operates
  • Meet emerging pricing and distribution concerns following health care reform
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.